These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1365450)

  • 41. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.
    Anand A; Verhoeff P; Seneca N; Zoghbi SS; Seibyl JP; Charney DS; Innis RB
    Am J Psychiatry; 2000 Jul; 157(7):1108-14. PubMed ID: 10873919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mapping of central D2 dopamine receptors in man using [11C]raclopride: PET with anatomic standardization technique.
    Ito H; Okubo Y; Halldin C; Farde L
    Neuroimage; 1999 Feb; 9(2):235-42. PubMed ID: 9927552
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.
    Farde L; Hall H; Ehrin E; Sedvall G
    Science; 1986 Jan; 231(4735):258-61. PubMed ID: 2867601
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.
    Chumpradit S; Kung MP; Billings J; Mach R; Kung HF
    J Med Chem; 1993 Jan; 36(2):221-8. PubMed ID: 8093734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
    Farde L; Suhara T; Nyberg S; Karlsson P; Nakashima Y; Hietala J; Halldin C
    Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
    Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
    Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine and depression--striatal dopamine D2 receptor SPECT before and after antidepressant therapy.
    Ebert D; Feistel H; Loew T; Pirner A
    Psychopharmacology (Berl); 1996 Jul; 126(1):91-4. PubMed ID: 8853222
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preclinical evaluation of [123I]R93274 as a SPECT radiotracer for imaging 5-HT2A receptors.
    Abi-Dargham A; Zea-Ponce Y; Terriere D; al-Tikriti M; Baldwin RM; Hoffer P; Charney D; Leysen JE; Laruelle M; Mertens J; Innis RB
    Eur J Pharmacol; 1997 Mar; 321(3):285-93. PubMed ID: 9085039
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PET studies of dopamine receptors in relation to antipsychotic drug treatment.
    Farde L; Nordström AL; Halldin C; Wiesel FA; Sedvall G
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():468A-469A. PubMed ID: 1354052
    [No Abstract]   [Full Text] [Related]  

  • 50. Continuous intravenous infusion of iodine-123-IBZM for SPECT determination of human brain dopamine receptor occupancy by antipsychotic agent RWJ-37796.
    Seibyl JP; Zea-Ponce Y; Brenner L; Baldwin RM; Krystal JH; Offord SJ; Mochoviak S; Charney DS; Hoffer PB; Innis RB
    J Nucl Med; 1996 Jan; 37(1):11-5. PubMed ID: 8543979
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
    Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Images in neuroscience. SPECT imaging of synaptic dopamine.
    Laruelle M; Innis RB
    Am J Psychiatry; 1996 Oct; 153(10):1249. PubMed ID: 8831430
    [No Abstract]   [Full Text] [Related]  

  • 53. Kinetic analysis of receptor binding with positron emission tomography.
    Eriksson L; Farde L; Rosenquist G
    Acta Radiol Suppl; 1991; 376():126-7. PubMed ID: 1666746
    [No Abstract]   [Full Text] [Related]  

  • 54. Preparation of [11C]- and [125I]IMB: a dopamine D-2 receptor antagonist.
    Wilson AA; Dannals RF; Ravert HT; Wagner HN
    Int J Rad Appl Instrum A; 1989; 40(5):369-73. PubMed ID: 2548972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurotransmitter receptor imaging in Alzheimer's disease.
    Sedvall G; Nybäck H; Farde L; Persson A
    J Neural Transm Suppl; 1987; 24():43-8. PubMed ID: 2824693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
    Seeman P; Van Tol HH
    J Neurochem; 1995 Mar; 64(3):1413-5. PubMed ID: 7861175
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective D1- and D2-dopamine receptor blockade both induces akathisia in humans--a PET study with [11C]SCH 23390 and [11C]raclopride.
    Farde L
    Psychopharmacology (Berl); 1992; 107(1):23-9. PubMed ID: 1534178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling dynamic PET-SPECT studies in the wavelet domain.
    Turkheimer FE; Banati RB; Visvikis D; Aston JA; Gunn RN; Cunningham VJ
    J Cereb Blood Flow Metab; 2000 May; 20(5):879-93. PubMed ID: 10826539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vivo imaging of dopamine reuptake sites in the primate brain using single photon emission computed tomography (SPECT) and iodine-123 labeled RTI-55.
    Shaya EK; Scheffel U; Dannals RF; Ricaurte GA; Carroll FI; Wagner HN; Kuhar MJ; Wong DF
    Synapse; 1992 Feb; 10(2):169-72. PubMed ID: 1585258
    [No Abstract]   [Full Text] [Related]  

  • 60. Positron emission tomography of brain dopamine D-2 receptors with 11C-raclopride in early Parkinson's disease.
    Laihinen A; Rinne JO; Någren K; Bergman J; Haaparanta M; Solin O; Ruotsalainen U; Rinne UK
    Acta Radiol Suppl; 1991; 376():151. PubMed ID: 1666759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.